Related Results
Four strengths of doxazosin approvedTeva, Apotex gain approval for doxazosinDoxazosin helps fight metabolic syndromeIvax receives tentative approval for doxazosin mesylate tabletsFinasteride and doxazosin combo halts BPH progress in 67%
> Teva gained FDA approva…
Doxazosin and finasteride, two widely used but not normally combined drugs, could strike a significant blow against symptoms of an enlarged prostate, according to a recent study in The New England Journal of Medicine. It reported on a five-year experiment with over 3,000 patients taking the drugs at 17 hospitals across the country.
Related Results
Four strengths of doxazosin approvedTeva, Apotex gain approval for doxazosinDoxazo…
Several generic drug companies have received approval for doxazosin mesylate tablets, the generic version of Pfizer Inc.’s Cardura. The product is for treating benign prostatic hyperplasis and general hypertension. Receiving Food and Drug Administration marketing clearance were Apotex Corp., KV Pharmaceutical Co., Faulding Inc., Teva Pharmaceuticals USA and Watson Pharmaceuticals Inc.
Related Results
Four strengths of doxazosin approvedTeva, Apotex ga…
